Current Ratio of Unicycive Therapeutics, Inc. from 31 Mar 2022 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Unicycive Therapeutics, Inc. quarterly Current Ratio in % history and change rate from 31 Mar 2022 to 30 Sep 2025.
  • Unicycive Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 205%, a 0.58% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Unicycive Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 205% -1.2% -0.58% 30 Sep 2025
Q2 2025 194% +26% +16% 30 Jun 2025
Q1 2025 218% +84% +62% 31 Mar 2025
Q4 2024 211% +87% +70% 31 Dec 2024
Q3 2024 206% +68% +49% 30 Sep 2024
Q2 2024 167% +16% +11% 30 Jun 2024
Q1 2024 134% -52% -28% 31 Mar 2024
Q4 2023 124% -165% -57% 31 Dec 2023
Q3 2023 138% -300% -68% 30 Sep 2023
Q2 2023 151% -664% -81% 30 Jun 2023
Q1 2023 186% -338% -65% 31 Mar 2023
Q4 2022 289% 31 Dec 2022
Q3 2022 438% 30 Sep 2022
Q2 2022 815% 30 Jun 2022
Q1 2022 524% 31 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.